This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Instem Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Phil Reason

Chief executive officer

UK£300.0k

Total compensation

CEO salary percentage78.7%
CEO tenureno data
CEO ownership3.2%
Management average tenure4.8yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

Here's Why We Think Instem (LON:INS) Might Deserve Your Attention Today

Oct 14
Here's Why We Think Instem (LON:INS) Might Deserve Your Attention Today

An Intrinsic Calculation For Instem plc (LON:INS) Suggests It's 29% Undervalued

Aug 31
An Intrinsic Calculation For Instem plc (LON:INS) Suggests It's 29% Undervalued

Instem plc (LON:INS) Shares Could Be 45% Below Their Intrinsic Value Estimate

Jan 25
Instem plc (LON:INS) Shares Could Be 45% Below Their Intrinsic Value Estimate

Instem plc's (LON:INS) Intrinsic Value Is Potentially 44% Above Its Share Price

Sep 04
Instem plc's (LON:INS) Intrinsic Value Is Potentially 44% Above Its Share Price

Is Instem plc's (LON:INS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Mar 03
Is Instem plc's (LON:INS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Shareholders Are Thrilled That The Instem (LON:INS) Share Price Increased 190%

Jan 29
Shareholders Are Thrilled That The Instem (LON:INS) Share Price Increased 190%

Calculating The Intrinsic Value Of Instem plc (LON:INS)

Dec 25
Calculating The Intrinsic Value Of Instem plc (LON:INS)

CEO Compensation Analysis

How has Phil Reason's remuneration changed compared to Instem's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

UK£3m

Mar 31 2023n/an/a

UK£4m

Dec 31 2022UK£300kUK£236k

UK£5m

Sep 30 2022n/an/a

UK£3m

Jun 30 2022n/an/a

UK£2m

Mar 31 2022n/an/a

UK£2m

Dec 31 2021UK£279kUK£204k

UK£2m

Sep 30 2021n/an/a

UK£2m

Jun 30 2021n/an/a

UK£2m

Mar 31 2021n/an/a

UK£2m

Dec 31 2020UK£276kUK£226k

UK£2m

Sep 30 2020n/an/a

UK£1m

Jun 30 2020n/an/a

UK£339k

Mar 31 2020n/an/a

-UK£292k

Dec 31 2019UK£261kUK£223k

-UK£923k

Sep 30 2019n/an/a

UK£418k

Jun 30 2019n/an/a

UK£2m

Mar 31 2019n/an/a

UK£2m

Dec 31 2018UK£243kUK£207k

UK£1m

Sep 30 2018n/an/a

UK£1m

Jun 30 2018n/an/a

UK£1m

Mar 31 2018n/an/a

UK£1m

Dec 31 2017UK£246kUK£210k

UK£642k

Sep 30 2017n/an/a

UK£470k

Jun 30 2017n/an/a

UK£297k

Mar 31 2017n/an/a

UK£678k

Dec 31 2016UK£241kUK£194k

UK£1m

Compensation vs Market: Phil's total compensation ($USD375.21K) is below average for companies of similar size in the UK market ($USD745.84K).

Compensation vs Earnings: Phil's compensation has been consistent with company performance over the past year.


CEO

Phil Reason (61 yo)

no data

Tenure

UK£300,000

Compensation

Mr. Phil J. Reason serves as the Chief Executive Officer of Instem LSS Limited, Instem Associates Limited and Instem plc (Instem Life Science Systems plc). Mr. Reason is an experienced chief executive who...


Leadership Team

NamePositionTenureCompensationOwnership
Phil Reason
CEO & Executive Directorno dataUK£300.00k3.2%
£ 6.4m
Nigel Goldsmith
CFO, Secretary & Executive Director12yrsUK£166.00k0.042%
£ 83.0k
Marybeth Thompson
Chief Operating Officer6.8yrsno datano data
Gordon Baxter
Chief Scientific Officerno datano datano data
Mark Poggi
Executive Vice President of Global Salesless than a yearno datano data
Eve Leconte
Chief People & Culture Officer4.8yrsno datano data
Mike Harwood
Chief Product Officerno datano datano data
Gregor Grant
Executive Vice President of Preclinical Solutionsno datano datano data
John Leveille
Executive Vice President of Clinical Trial Accelerationless than a yearno data1.79%
£ 3.6m

4.8yrs

Average Tenure

Experienced Management: INS's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Phil Reason
CEO & Executive Directorno dataUK£300.00k3.2%
£ 6.4m
Nigel Goldsmith
CFO, Secretary & Executive Director12yrsUK£166.00k0.042%
£ 83.0k
Riaz Bandali
Independent Non-Executive Director1.9yrsUK£36.00kno data
Michael McGoun
Non-Executive Directorno dataUK£40.00kno data
David Gare
Non-Executive Chairmanno dataUK£65.00k5.52%
£ 11.0m
Mary Dolson
Independent Non-Executive Directorless than a yearno datano data

1.9yrs

Average Tenure

62.5yo

Average Age

Experienced Board: INS's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/21 04:11
End of Day Share Price 2023/11/20 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Instem plc is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Greig AitkenNplus1 Brewin
Christopher GlasperNplus1 Brewin
Gareth EvansProgressive Equity Research